- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Loxo-195
Total 260 results
-
BayerNo longer availableSolid Tumors Harboring NTRK Fusion
-
BayerCompletedSolid Tumors Harboring NTRK FusionUnited States, Belgium, Italy, Germany, Australia, Spain, Singapore, Denmark, France, Ireland
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingCentral Nervous System Neoplasm | Solid Neoplasm | Recurrent Acute Leukemia | Refractory Acute Leukemia | Infantile FibrosarcomaUnited States, Canada
-
Boehringer IngelheimCompletedVenous InsufficiencyGermany
-
Eli Lilly and CompanyLoxo Oncology, Inc.CompletedHealthyUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.Not yet recruiting
-
Boehringer IngelheimCompletedVenous InsufficiencyGermany, Austria, Czech Republic
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMetastatic Renal Cell Carcinoma | Fumarate Hydratase Deficient Renal Cell Carcinoma | Succinate Dehydrogenase Deficient Renal Cell CarcinomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterXencor, Inc.Active, not recruiting
-
Kaleido BiosciencesCompleted
-
Eli Lilly and CompanyLoxo Oncology, Inc.CompletedHealthy | Renal InsufficiencyUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyCompletedHealthyUnited States
-
Kaleido BiosciencesTerminatedUrea Cycle DisorderBelgium, United States, Spain, United Kingdom, Germany, Switzerland, Turkey
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruiting
-
Eli Lilly and CompanyLoxo Oncology, Inc.CompletedHealthy | Hepatic ImpairmentUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyCompletedHealthyUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
MSI Methylation Sciences, Inc.CompletedMajor Depressive Disorder (MDD)United States
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingMedullary Thyroid CancerUnited States, Canada, Spain, China, Taiwan, Australia, Japan, India, Belgium, Germany, France, Netherlands, Czechia, Brazil, Korea, Republic of, United Kingdom, Italy, Israel, Greece, Poland, Russian Federation
-
Eli Lilly and CompanyLoxo Oncology, Inc.Recruiting
-
Eli Lilly and CompanyLoxo Oncology, Inc.Active, not recruitingCarcinoma, Non-Small-Cell Lung | Thyroid NeoplasmsUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.No longer availableCarcinoma, Non-Small-Cell Lung | Thyroid Neoplasms
-
Loxo Oncology, Inc.Eli Lilly and CompanyAvailableBreast Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Colon Cancer | Medullary Thyroid Cancer | Papillary Thyroid Cancer | Other Solid Tumors With Evidence of Activating RET AlterationSpain, United States, Australia, France, Germany, Israel, Italy, Japan, New Zealand, Poland, Singapore, Switzerland
-
Loxo Oncology, Inc.Eli Lilly and CompanyCompleted
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingCarcinoma, Non-Small-Cell LungUnited States, Denmark, Taiwan, China, Canada, Spain, Germany, Japan, United Kingdom, Brazil, India, Korea, Republic of, Australia, Italy, Norway, Israel, Greece, Turkey, Netherlands, Austria, Belgium, Hong Kong, Poland, Puerto Rico, Cz... and more
-
M.D. Anderson Cancer CenterRecruitingRecurrent Thyroid Gland Carcinoma | Poorly Differentiated Thyroid Gland Carcinoma | Thyroid Gland Anaplastic Carcinoma | Thyroid Gland Squamous Cell Carcinoma | Thyroid Gland Medullary Carcinoma | Thyroid Gland Papillary Carcinoma | Malignant Thyroid Gland NeoplasmUnited States
-
M.D. Anderson Cancer CenterCompletedEvaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid MalignanciesAcute Myeloid Leukemia | Myeloproliferative Disorders | Chronic Myelomonocytic Leukemia | Anemia, Refractory, With Excess of BlastsUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Actinium PharmaceuticalsCompletedLeukemia | Myelodysplastic SyndromeUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.Active, not recruitingLymphoma, Non-Hodgkin | B-cell Lymphoma | Multiple Myeloma | Lymphoma, Mantle-Cell | Waldenstrom Macroglobulinemia | Leukemia, Lymphocytic, Chronic, B-Cell | Lymphoma, B-cell Marginal ZoneUnited States, France, Poland, Italy
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingSmall Cell Lung Carcinoma | Small-cell Lung CancerUnited States
-
BayerCompletedA Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat CancerSolid Tumors Harboring NTRK FusionUnited States
-
MSI Methylation Sciences, Inc.Algorithme Pharma IncCompletedMajor Depressive Disorder
-
University of AarhusCompletedHeart FailureDenmark
-
Chr HansenCompletedReduction of Small Intestinal Ulceration RiskUnited States
-
BayerActive, not recruitingSolid Tumors Harboring NTRK FusionUnited States, China, Poland, Australia, Germany, Japan, Canada, Italy, Czechia, Spain, Turkey, United Kingdom, Sweden, Netherlands, France, Switzerland, Korea, Republic of, Denmark, Ireland, Israel, Ukraine
-
Ain Shams UniversityRecruitingVentriculitis, InfectiousEgypt
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingSoft Tissue Sarcoma | Medullary Thyroid Cancer | Papillary Thyroid Cancer | Infantile Fibrosarcoma | Infantile MyofibromatosisUnited States, Australia, Japan, Canada, Germany, Korea, Republic of, France, Spain, United Kingdom, Denmark, Italy
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingNon-Small Cell Lung Cancer | Colon Cancer | Medullary Thyroid Cancer | Any Solid TumorUnited States, Japan, Taiwan, Australia, Korea, Republic of, Israel, Spain, Switzerland, Singapore, France, Canada, Italy, Germany, United Kingdom, Hong Kong, Denmark
-
TakedaTerminated
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
BayerActive, not recruitingSolid Tumors Harboring NTRK FusionUnited States, Korea, Republic of, China, Japan, India, France, Turkey, Portugal, Spain, Taiwan, Czechia, Sweden, Brazil, Denmark, Singapore, Argentina, Germany, Ireland
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Memorial Sloan Kettering Cancer CenterEMD SeronoRecruitingMerkel Cell CarcinomaUnited States
-
Kaleido BiosciencesCompletedUrea Cycle DisordersSwitzerland
-
BayerApproved for marketingTumors Harboring NTRK Fusion
-
Chr HansenAtlantia Food Clinical TrialsTerminatedReduction of Small Intestinal Ulceration RiskUnited States
-
University of LuebeckCompleted